We work with clinicians across oncology, nursing, allied health professions, and primary care to better understand real-world communication challenges in IMCT.

Collaborations may include:

• co-developing research questions

• contributing clinical insight to study design

• helping integrate research into clinical pathways

• supporting recruitment to studies ption text goes here

We collaborate with researchers across disciplines, including:

• oncology

• immunology

• health services research

• implementation science

• health inequalities

• digital health and data science

• computational modelling and big data

• methodology

We are particularly interested in interdisciplinary collaborations that bridge the lab to bedside.

Industry plays a key role in the development of new immune-mediated cancer treatments.

We welcome collaboration with industry partners interested in:

• understanding patient perspectives on IMCT

• improving communication around treatment benefits and risks

• supporting patient-centred approaches to treatment development

• generating evidence to inform patient information and education

Our work aims to complement scientific and clinical innovation by improving how treatments are explained and experienced.

Cancer charities, advocacy organisations, and patient groups are essential partners in shaping meaningful research.

We collaborate with organisations to:

• identify patient priorities

• design accessible research materials

• encourage wide participation in research

• improve how research findings are shared with patients and the public

• support inclusive and equitable engagement

Community organisations and support groups provide valuable insight into the experiences of people affected by cancer. 

We are particularly interested in working with groups that support underrepresented or underserved communities, to help ensure our research reflects diverse perspectives and experiences.